Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and CapecitabineEdith A. Perez, Gabriel N. Hortobágyi, Guillermo Lerzo et al.|Journal of Clinical Oncology|2007Cited by 392
Phase II Clinical Trial of Ixabepilone (BMS-247550), an Epothilone B Analog, in Patients With Taxane-Resistant Metastatic Breast CancerEva Thomas, Miguel Martín, Josep Tabernero et al.|Journal of Clinical Oncology|2007Cited by 290
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysisFrançois‐Clément Bidard, Paul Cottu, Bjørn Naume et al.|JNCI Journal of the National Cancer Institute|2018Cited by 282